Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $8.4 million.

  • Jaguar Health's Accounts Payables rose 8547.89% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 8547.89%. This contributed to the annual value of $5.3 million for FY2024, which is 627.26% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's Accounts Payables is $8.4 million, which was up 8547.89% from $6.6 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Accounts Payables ranged from a high of $8.4 million in Q3 2025 and a low of $3.3 million during Q1 2024
  • Over the past 5 years, Jaguar Health's median Accounts Payables value was $5.0 million (recorded in 2023), while the average stood at $5.2 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first plummeted by 4167.25% in 2024, then surged by 11168.67% in 2025.
  • Quarter analysis of 5 years shows Jaguar Health's Accounts Payables stood at $4.9 million in 2021, then grew by 17.83% to $5.8 million in 2022, then decreased by 14.36% to $5.0 million in 2023, then increased by 6.27% to $5.3 million in 2024, then skyrocketed by 59.72% to $8.4 million in 2025.
  • Its last three reported values are $8.4 million in Q3 2025, $6.6 million for Q2 2025, and $7.0 million during Q1 2025.